PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.39 -0.01 (-1.63%)
As of: Nov 12, 2026 · 10:14 AM EST

PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2009 - 2013)

Updated

PharmaCyte Biotech's Return on Sales [ROS] came in at -40488.52% for fiscal Q1 2014 (quarter ended Jul 31, 2013), down 32357.12 percentage points from -8131.39% a year earlier and down 27450.43 percentage points from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2009 - 2013) Analysis & Trends

For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech's Return on Sales [ROS] was -13851.65%, down 10923.11 percentage points from FY2012.

  • Going back by fiscal year, Return on Sales [ROS] was -2928.55% in FY2012 (-2620.32 pp) and -308.23% in FY2011.
  • The fiscal Q1 2014 figure represents the lowest quarterly Return on Sales [ROS] in data going back to fiscal Q1 2011.
  • Year-over-year, Return on Sales [ROS] has declined for nine consecutive quarters, with an average year-over-year change of -7967.26 percentage points over the last eight quarters.
  • The year-over-year drop in Return on Sales [ROS] has ranged between 1807.74 percentage points (fiscal Q3 2012) and 32357.12 percentage points (fiscal Q1 2014) over the last five years.
  • Business Quant data shows PMCB's Return on Sales [ROS] at -13038.09% (Q4 2013), -8733.76% (Q3 2013) and -5547.89% (Q2 2013) in the three fiscal quarters before Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 PharmaCyte Biotech 4.29 Mn -68.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2013 -40,488.52%
Apr 30, 2013 -13,038.09%
Jan 31, 2013 -8,733.76%
Oct 31, 2012 -5,547.89%
Jul 31, 2012 -8,131.39%
Apr 30, 2012 -7,227.51%
Jan 31, 2012 -2,022.51%
Oct 31, 2011 -2,034.52%
Jul 31, 2011 -3,302.30%
Apr 30, 2011 -432.24%
Jan 31, 2011 -214.77%
Oct 31, 2010 -120.85%
Jul 31, 2010 -294.27%
Apr 30, 2010 -5,138.18%
Jan 31, 2010 -78.03%
Oct 31, 2009 -690.29%
Jul 31, 2009 -1,421.26%
Apr 30, 2009 -5,727.23%
Jan 31, 2009 -679.51%
API Access

PharmaCyte Biotech Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY